HK:2616 Stock Latest News
Company AnnouncementsCStone’s Trispecific Cancer Antibody Hits Key Clinical Milestone Ahead of Global Phase III Push1w ago2616
Company AnnouncementsCStone CEO Boosts Stake Ahead of Key Clinical Data Milestone1M ago2616
Company AnnouncementsCStone Pharmaceuticals Gains Southbound Stock Connect Access as Pipeline Advances1M ago2616- Company AnnouncementsCStone Revenues Soar on NRDL-Driven Cancer Drug Sales as Loss Narrows in H1 20262M ago2616
Company AnnouncementsCStone’s CS5001 Trial Pause: What the Early Cancer Study Update Means for Investors2M ago2616
Company AnnouncementsCStone Gains Rapid China IND Approval for EGFR/HER3 ADC CS50072M ago2616Company AnnouncementsCStone Pharmaceuticals Sets Board Meeting to Review Interim Results and Consider Dividend2M ago2616
Company AnnouncementsCStone Management Boosts Shareholdings as Key Immuno-Oncology Asset Advances3M ago2616
- Company AnnouncementsCStone’s Trispecific Cancer Antibody CS2009 Secures Dual Rapid Oral Slots at ESMO 20263M ago2616
Company AnnouncementsCStone Strikes Oceania Deal with Arrotex for Cancer Drug Sugemalimab4M ago2616- Company AnnouncementsCStone Shareholders Approve All AGM Resolutions, Renew Capital Mandates and CEO Equity Awards4M ago2616
- Company AnnouncementsCStone’s New EGFR–HER3 Drug CS5007 Enters First-in-Human Testing: What Investors Should Know4M ago2616
Company AnnouncementsCStone Seeks Independent Shareholder Approval for CEO Equity Awards4M ago2616Company AnnouncementsCStone Launches Global Phase I Trial for New EGFR/HER3 Bispecific ADC4M ago2616
Company AnnouncementsCStone Executives Launch Joint Share Purchase Plan to Signal Confidence in Pipeline5M ago2616
- Company AnnouncementsCStone Sets 2026 AGM to Renew Board, Auditor and Share Issuance Mandate5M ago2616
Company AnnouncementsCStone’s CS2009 Posts Strong ASCO Data as Company Prepares Global Phase III Trial5M ago2616
Company AnnouncementsCStone Pharmaceuticals Unveils Share Buyback Plan After Key Oncology Data Milestone5M ago2616
Company AnnouncementsCStone Launches Nationwide Supply of Locally Made Pralsetinib as China Sales Surge5M ago2616
Company AnnouncementsCStone Pharmaceuticals Raises Over HK$1 Billion in Completed Share Placement6M ago2616Company AnnouncementsCStone to Showcase Promising CS2009 Cancer Data Ahead of Global Phase III Push6M ago2616
Company AnnouncementsCStone Showcases Three Novel ADC Candidates, Highlighting EGFR/HER3 Bispecific CS50076M ago2616